FDA NDC Directory · JSON-LD · Markdown
NDC 76420-865 · HUMAN PRESCRIPTION DRUG · TABLET
| Labeler / Manufacturer | Asclemed USA, Inc. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA076286 |
| Dosage form / route | TABLET · ORAL |
| Active ingredients | TIZANIDINE HYDROCHLORIDE (2 mg/1) |
| Marketing started | 20210615 |
| Package count | 5 |
Source: openFDA. Public-domain (CC0).